Publications by authors named "Gordon Irving"

Claim this Profile
T
The Effect of Gabapentin Enacarbil on Pain Associated with Moderate-to-Severe Primary Restless Legs Syndrome in Adults: Pooled Analyses from Three Randomized Controlled Trials.
Neal Hermanowicz, Aaron Ellenbogen, Gordon Irving, Mark Buchfuhrer, Mark J Jaros

CNS Drugs· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety of gastroretentive gabapentin in postherpetic neuralgia patients.
Mark P Jensen, Gordon Irving, Richard Rauck, Mark Wallace, Mike Sweeney

Clin J Pain· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily gastroretentive gabapentin for postherpetic neuralgia: integrated efficacy, time to onset of pain relief and safety analyses of data from two phase 3, multicenter, randomized, double-blind, placebo-controlled studies.
Richard L Rauck, Gordon A Irving, Mark S Wallace, Geertrui F Vanhove, Michael Sweeney

J Pain Symptom Manage· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tolerability and safety of gastroretentive once-daily gabapentin tablets for the treatment of postherpetic neuralgia.
Gordon A Irving, Michael Sweeney

J Pain Res· October 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily gastroretentive gabapentin for the management of postherpetic neuralgia: an update for clinicians.
Gordon Irving

Ther Adv Chronic Dis· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Once-daily gastroretentive gabapentin for treatment of postherpetic neuralgia.
Gordon Irving

Pain Manag· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic neuralgia.
Gordon A Irving, Miroslav Backonja, Richard Rauck, Lynn R Webster, Jeffrey K Tobias

Clin J Pain· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duloxetine, pregabalin, and duloxetine plus gabapentin for diabetic peripheral neuropathic pain management in patients with inadequate pain response to gabapentin: an open-label, randomized, noninferiority comparison.
Robert J Tanenberg, Gordon A Irving, Richard C Risser, Jonna Ahl, Michael J Robinson

Mayo Clin Proc· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
Gordon Irving, Janos Pénzes, Brian Ramjattan, Michael Cousins, Richard Rauck

J Pain· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia.
Gordon A Irving, Miroslav M Backonja, Edwin Dunteman, E Richard Blonsky, Geertrui F Vanhove

Pain Med· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The placebo response: relationship to outcomes in trials of postherpetic neuralgia.
Gordon Irving

Clin Drug Investig· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gabapentin extended-release tablets for the treatment of patients with postherpetic neuralgia: a randomized, double-blind, placebo-controlled, multicentre study.
Mark S Wallace, Gordon Irving, Verne E Cowles

Clin Drug Investig· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative sensory testing and mapping: a review of nonautomated quantitative methods for examination of the patient with neuropathic pain.
David Walk, Nalini Sehgal, Tobias Moeller-Bertram, Robert R Edwards, Ajay Wasan, Gordon Irving

Clin J Pain· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative sensory testing in measurement of neuropathic pain phenomena and other sensory abnormalities.
Miroslav-Misha Backonja, David Walk, Robert R Edwards, Nalini Sehgal, Toby Moeller-Bertram, Gordon Irving

Clin J Pain· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multimodal analgesia for chronic pain: rationale and future directions.
Charles E Argoff, Phillip Albrecht, Gordon Irving, Frank Rice

Pain Med· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and tolerability of gastric-retentive gabapentin for the treatment of postherpetic neuralgia: results of a double-blind, randomized, placebo-controlled clinical trial.
Gordon Irving, Mark Jensen, Marilou Cramer, Jacqueline Wu, Yu-Kun Chiang

Clin J Pain· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alvimopan, a peripherally acting mu-opioid receptor (PAM-OR) antagonist for the treatment of opioid-induced bowel dysfunction: results from a randomized, double-blind, placebo-controlled, dose-finding study in subjects taking opioids for chronic non-cancer pain.
Lynn Webster, Jan Peter Jansen, John Peppin, Ben Lasko, Gordon Irving

Pain· July 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetic peripheral neuropathic pain: clinical and quality-of-life issues.
Charles E Argoff, B Eliot Cole, David A Fishbain, Gordon A Irving

Mayo Clin Proc· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consensus guidelines: treatment planning and options. Diabetic peripheral neuropathic pain.
Charles E Argoff, Misha-Miroslav Backonja, Miles J Belgrade, Gary J Bennett, Michael R Clark, Gordon A Irving

Mayo Clin Proc· April 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational multidrug therapy in the treatment of neuropathic pain.
Misha-Miroslav Backonja, Gordon Irving, Charles Argoff

Curr Pain Headache Rep· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary assessment and management of neuropathic pain.
Gordon A Irving

Neurology· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cognitive effects of opioids.
Mary Ersek, Monique M Cherrier, Steven S Overman, Gordon A Irving

Pain Manag Nurs· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Description and predictors of direct and indirect costs of pain reported by cancer patients.
Barry V Fortner, Gail Demarco, Gordon Irving, Jeri Ashley, Ginny Keppler

J Pain Symptom Manage· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of tourniquet ischemia on current perception thresholds in healthy volunteers.
Georgeann C Baron, Gordon A Irving

Pain Pract· June 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis